New PET Probes: A new way to streamline the IND process for FDA approval
Los Angeles, CA USA – June 4, 2014 – A recent article published in Molecular Imaging and Biology, the journal of the World Molecular Imaging Society, discusses a streamlined and cost-effective approach to obtain Investigational New Drug (IND) approvals from the Food and Drug Administration (FDA) for positron emission tomography (PET) imaging probes. The article “de-mystifies” the process and provides a straightforward description on how to achieve approval for an imaging trial.
To read the full press release please click here.
To log in to the Molecular Imaging and Biology journal, please click here.